華夏恒生生科：2024年度報告.pdf

1、 ChinaAMC Global ETF Series ChinaAMC Hang Seng Biotech ETF Annual Report For the year ended 31 December 2024 ANNUAL REPORT ChinaAMC Hang Seng Biotech ETF(formerly known as ChinaAMC Hang Seng Hong Kong Biotech Index ETF).(Stock Code:03069(HKD Counter)and 09069(USD Counter)and 83069(RMB Counter)(a sub

2、-fund of ChinaAMC Global ETF Series)For the year ended 31 December 2024 1 ChinaAMC Hang Seng Biotech ETF (formerly known as ChinaAMC Hang Seng Hong Kong Biotech Index ETF)(a Sub-Fund of ChinaAMC Global ETF Series)CONTENTS Pages MANAGEMENT AND ADMINISTRATION 1 2 REPORT OF THE MANAGER TO THE UNITHOLDE

3、RS 3 4 REPORT OF THE TRUSTEE TO THE UNITHOLDERS 5 STATEMENT OF RESPONSIBILITIES OF THE MANAGER AND THE TRUSTEE 6 INDEPENDENT AUDITORS REPORT 7 11 AUDITED FINANCIAL STATEMENTS Statement of financial position 12 Statement of profit or loss and other comprehensive income 13 Statement of changes in net

4、assets attributable to unitholders 14 Statement of cash flows 15 16 Notes to the financial statements 17 46 INVESTMENT PORTFOLIO(Unaudited)47 48 MOVEMENTS IN INVESTMENT PORTFOLIO(Unaudited)49 50 PERFORMANCE RECORD(Unaudited)51 DETAILS OF SECURITY LENDING ARRANGEMENTS(Unaudited)52 54 HOLDING OF COLLA

5、TERAL(Unaudited)55 57 IMPORTANT:Any opinion expressed herein reflects the Managers view only and is subject to change.For more information about the Sub-Fund,please refer to the prospectus of the Sub-Fund which is available at our website:https:/.hk/product/chinaamc-hang-seng-hong-kong-biotech-index

6、-etf-3069-hk-9069-hk/#prospectusDocuments Investors should not rely on the information contained in this report for their investment decisions.1 ChinaAMC Hang Seng Biotech ETF (formerly known as ChinaAMC Hang Seng Hong Kong Biotech Index ETF)(a Sub-Fund of ChinaAMC Global ETF Series)MANAGEMENT AND A